Pharmaceuticals

Gene Therapy Market Report 2026: Strategic Insights and Revenue Outlook

February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the gene therapy market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Gene Therapy Market between 2026 and 2030?

The gene therapy market has witnessed substantial growth in recent years. It is anticipated to expand from $16.36 billion in 2025 to $21.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 31.2%. This historical growth can be attributed to the rising prevalence of genetic disorders, progress in viral vector technology, increasing r&d investments in gene therapy, favorable government policies, and a greater awareness of rare diseases.

The gene therapy market is projected to experience substantial expansion in the coming years, reaching a valuation of $35.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.5%. This anticipated growth during the forecast period is driven by factors such as the increasing reach of personalized medicine, the rise of CRISPR and other gene editing treatments, a boost in both private and public financial backing, the incorporation of AI into gene therapy investigations, and an increase in joint international clinical trials. Key trends expected within this period encompass the development of personalized gene therapies, the wider uptake of CRISPR and gene editing technologies, the broadening of regulatory and ethical guidelines, advancements in both viral and non-viral vector innovations, and intensified collaborative research and clinical trials.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Gene Therapy Market?

The increasing investment in the healthcare industry is projected to drive the expansion of the gene therapy market moving forward. Healthcare industry investment pertains to directing funds towards companies that deliver medical services, manufacture medical equipment or drugs, provide medical insurance, or otherwise contribute to the healthcare sector. This investment is crucial for the gene therapy industry, as various pharmaceutical companies are investing to strengthen their patent portfolios and establish profitable partnerships. Strategic investments also aid in the advancement of new and innovative gene therapy products. For instance, in April 2025, the American Medical Association, a US-based Professional organizations, reported that U.S. health spending in 2023 increased by 7.5% to $4.9 trillion, or $14,570 per capita, surpassing the 4.6% growth observed in 2022. Thus, the escalating investment in the healthcare industry is propelling the gene therapy market’s growth.

How Is The Gene Therapy Market Organized Into Various Segments?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Which Trends Are Expected To Influence The Gene Therapy Market In The Upcoming Years?

Leading companies within the gene therapy market are prioritizing the development of advanced products, including adeno-associated virus (AAV) vectors, to enhance the precision and effectiveness of gene delivery for the treatment of various genetic disorders. An adeno-associated virus (AAV) vector serves as a frequently used tool in gene therapy to transport genetic material into cells. For example, in April 2024, Pfizer Inc., a US-based global biopharmaceutical company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency dedicated to protecting public health, for BEQVEZ (fidanacogene elaparvovec-dzkt). This gene therapy, BEQVEZ (fidanacogene elaparvovec-dzkt), is designed to treat adults suffering from moderate to severe hemophilia B, a genetic bleeding disorder characterized by a deficiency in clotting factor IX (FIX) which can result in excessive bleeding. It utilizes an adeno-associated virus (AAV) vector to deliver a functional copy of the FIX gene directly into liver cells, thereby supporting the natural production of this crucial clotting factor.

Who Are The Primary Competitors In The Global Gene Therapy Market?

Major companies operating in the gene therapy market are UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Gene Therapy Market?

North America was the largest region in the gene therapy market in 2025. The regions covered in the gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gene Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Browse Through More Reports Similar to the Global Gene Therapy Market 2026, By The Business Research Company

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795